Contact us
![]() |
customer@davidpublishing.com |
![]() |
3275638434 |
![]() |
![]() |
| Paper Publishing WeChat |
Useful Links
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Article
Author(s)
Rajaona Ranto Andriatsilavina, Razafindrajao Tsiorinirina Fabien, Raharimanantsoa Onja Lalaina, and Raobela Léa
Full-Text PDF
XML 64 Views
DOI:10.17265/1548-6648/2026.01.001
Affiliation(s)
Ophthalmology Department, Joseph Ravoahangy Andrianavalona University Hospital, Antananarivo, Madagasca
ABSTRACT
Abstract: Objectives: To evaluate the functional and anatomical outcomes of severe forms of
diabetic retinopathy (DR) after treatment, and to identify factors associated
with improved visual acuity (VA). Patients and Methods: This was an
observational analytical study conducted in the Ophthalmology Department of
Joseph Ravoahangy Andrianavalona University Hospital (Antananarivo), including
diabetic patients with severe forms of DR, treated and followed between
December 2021 and June 2024. Demographic, clinical, paraclinical, therapeutic,
and follow-up data were collected. Results: Out of 135 records,
100 patients were included (mean age 58.9±8.5 years, 58% male). Proliferative
complicated DR predominated (67%), and maculopathy was present in 45% of cases.
At six months, VA had improved in 50% of patients, and regression of lesions
was observed in 96%. Factors significantly associated with visual improvement
were: absence of cataract (RR = 1.9), absence of maculopathy (RR = 1.7),
completion of at least 3,000 laser impacts (RR = 1.5), vitrectomy (RR = 1.6),
treatment with bevacizumab (RR = 1.5), and combined therapy (anti-VEGF plus
laser plus vitrectomy) (RR = 1.6). Well-controlled hypertension under
monotherapy was also associated with a better functional prognosis (RR = 1.6). Conclusion: Even at an advanced stage, intensive treatment can achieve functional
improvement and/or stabilization in patients with severe DR.
KEYWORDS
Bevacizumab, laser photocoagulation, Madagascar, diabetic retinopathy, vitrectomy.
Cite this paper
References




